Ongoing research into nutritional and exercise interventions, as well as novel pharmacological agents such as myostatin/activin pathway inhibitors (243) or agents targeting the apelin pathway (244) holds promise for preserving lean mass and improving overall health in patients undergoing treatment with GLP-1 and dual GIP/GLP-1 receptor agonists
Sulfur burps may also be caused by an underlying GERD issue, in which case limiting acidic foods, spicy foods, and alcohol as well as remaining upright for two to three hours after eating can help
The projected timeline for remaining pivotal trials is early to mid-2026, with data publication expected shortly thereafter
This scientifically-backed method enhances bioavailability, offering a non-invasive alternative to oral supplements
This level suits researchers primarily interested in metabolic health improvements like insulin sensitivity and lipid panel normalization, where extreme weight loss is not the primary goal
Dulaglutide (Trulicity): Primarily prescribed for type 2 diabetes, this once-weekly injection may have some off-label use for weight management
